Anugula, Dixitha
Cardoso, Rhanderson
Grandhi, Gowtham R.
Blankstein, Ron
Nasir, Khurram
Al-Mallah, Mouaz
Shah, Dipan J.
Cainzos-Achirica, Miguel
Article History
Accepted: 9 June 2022
First Online: 30 August 2022
Declarations
:
: Dr. Khurram Nasir is on the advisory board of Amgen, Novartis, and Novo Nordisk. His research is partly supported by the Jerold B. Katz Academy of Translational Research. The other authors declare that they have no conflicts of interest relevant to the content of this manuscript.
: This article does not contain any studies with human or animal subjects performed by any of the authors.